This brand name is authorized in Nigeria.
The drug FANMET contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
6A9O50735X - ARTENIMOL
|
|
Artemisinin is used in the treatment of malaria due to species Plasmodium. |
|
2
|
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-0560 | Capsule | FANMET CAPSULES CAP 40 mg; 320 mg 1X9CAPSULES | 59 CMS-PP-372960 FANMET CAPSULES DIHYDROARTEMISININ 40G, PIPERAQUINE PHOSPHATE 320MG DIHYDROARTEMISININ 40MG, PIPERAQUINE PHOSPHATE 320mg - maize starch, crosspovidone, PVP K-30, ISOPROPYL ALCOHOL, PURIFIED TALC, COLLOIDAL ANHYDROUS SILICA, Mg stearate. A4-0560 Drugs Imported Products 1X9CAPSULES Over The Counter (OTC) 11/5/2023 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com MAXHEAL LABORATORIES PVT LTD, PLOT NO. 2-7/80-85 SURSEZ SACHIN DIST. SURAT GUJARAT 394 230 INDIA, India | 21/12/2023 |
| A4-6737 | Powder for suspension | Fanmet Powder for Oral Suspension PWD_F_SOL 80 mg/80 mL; 640 mg/80 mL 1 x 80 mL | Powder for Oral Suspension | 28/01/2021 |
| B4-2194 | Tablet | Fanmet Tablets TAB 40 mg; 320 mg 1 x 8's | Tablet | 25/02/2021 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-0560, A4-6737, B4-2194 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.